ICMR aims to launch Coronavirus vaccine “COVAXIN” by August 15

78

New Delhi: The Indian Council of Medical Research (ICMR) has informed that it aims to launch the Coronavirus vaccine being developed in partnership with Hydereabad-based Bharat Biotech for public health use by August 15.

The Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL) have come together to step up efforts for a possible vaccine for the novel coronavirus.

ICMR expects to launch the Covid vaccine by August 15 after completion of clinical trials. To step up these efforts, ICMR has written to all stockholders to treat it as top priority.

ICMR has developed the indigenous Covid-19 vaccine (BBV152 COVID vaccine) partnered with BBIL. The ICMR has selected 12 institutes for clinical trial of the country’s first indigenous Covid-19 vaccine, an official had said on Thursday.

“You have been chosen as a clinical trial site of the BBV152 COVID Vaccine. In view of the public health emergency due to COVID-19 pandemic and urgency to launch the vaccine, you are strictly advised to fast track all approvals related to the initiation of the clinical trial and ensure that the subject enrollment is initiated no later than 7th July 2020,” ICMR’s statement read.

The country’s apex medical body has selected 12 institutes, including one from Odisha, for the clinical trial of the country’s first indigenous COVID-19 vaccine, an official said on Thursday. In view of the public health emergency due to COVID-19 pandemic and urgency to launch the vaccine, the selected institutes are strictly advised to fast track all approvals related to the initiation of the clinical trial and ensure that the subject enrolment is initiated during the first week of July.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.